David Dingli

Hematologist with expertise in multiple myeloma, amyloidosis, hematopoiesis, stem cell transplantation, PNH, mathematical and computational modeling.

[David Dingli @david_dingli]

Congratulations to Dr Liu for her publication on macrophage/plasma cells/CAR-T interactions. https://t.co/smXhtcR0EM

[David Dingli @david_dingli]

Just published: T cell redirecting therapy for multiple myeloma. Work with two remarkable advanced fellows in myeloma.
https://t.co/RE1OiWpPOX

[Mayo Clinic Transplant @MayoTransplant]

Join us!

[Amyloidosis @Amyloidosisfdn]

More awareness=earlier diagnosis

[David Dingli @david_dingli]

At ASH2024 we presented data on FTIR/AI analysis of serum for early diagnosis of AL amyloidosis where timing is critical.

[David Dingli @david_dingli]

Proud of my continued collaboration with the team at Oncodea. We can distinguish between stable MGUS from@smoldering myeloma for proper risk stratification

[Gianrico Farrugia @GFarrugiaMD]

Today Mayo Clinic announced the world's first known successful total larynx transplant performed in a patient with an active cancer as part of a clinical trial. This breakthrough paves the way for more treatment options and clinical trials. Read more: https://t.co/xIbV6Nb9JQ

[David Dingli @david_dingli]

Intravascular and Extravascular Hemolysis MoA in PNH https://t.co/ACMpj04sZw via @AJMC

[David Dingli @david_dingli]

PNH Overview and Pathophysiology https://t.co/a5PphrhInv via @AJMC

[Decera Clinical Education @DeceraClinEdu]

Join @DingliMD December 8 for a satellite symposium on the latest data on the diagnosis and management of cold agglutinin disease (CAD).

Listen to what else David Dingli, MD, PhD has to say: https://t.co/hZMg2N2XDy

[Decera Clinical Education @DeceraClinEdu]

Want the latest in #hematology? Join expert faculty for a free hematology symposium preceding the 65th ASH Annual Meeting in sunny San Diego. The best part? No ASH registration is required. See you there! 🌞 https://t.co/XZ0a1HPV78

[nature @Nature]

In a world first, the UK medicines regulator has approved a therapy that uses CRISPR gene editing as a treatment for diseases https://t.co/s1uvJVJasN

[Benjamin Werner @BenjaminWerner_]

I am very happy to share a new preprint together with Iftikhar Ahmed, @david_dingli and @huang_weini that just came out

https://t.co/vQOEfcb7aL

In it we discuss how a hierarchical tissue structure changes clonal fitness over time.

[AmyC4433 @ColemanFam7]

Received the best news today! The #Carvykti Car-T cell therapy I completed at @MayoClinic last Friday was successful! I am in REMISSION!!! #multiplemyeloma #bloodcancer @david_dingli #mmrf

[Eric Topol @EricTopol]

The booster we really need right now is to block infections and transmission

[Mathoncoblog @mathoncoblog]

🌍 It's #MathOnco groups highlighting again: Today, we invite you to explore the Quantitative Personalized Oncology Lab by @HeikoEnderling at @MoffittNews in Tampa, Florida, USA. Check out the group: https://t.co/C7XE9xiATa ⬇️

[Oxford Mathematics @OxUniMaths]

"91 is a much more mathematically interesting number than 90" - R. Penrose, 8th August 2022.

Today is Nobel laureate Roger's 91st birthday, so here is a picture of him taken an hour ago, shortly before he sat down to tea and cake and cosmology.

[Morie Gertz @MorieGertz]

Why is a multiple myeloma patient never refractory to dexamethasone. After progressing through the last steroid regimen why do we punish them by continuing to give Them dexamethasone for the seventh regimen

[David Dingli @david_dingli]

Wonderful winter recital yesterday By #SEMYO at Lourdes High School